ADAmal Mohamed Dawoud

Amal Mohamed Dawoud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amal Mohamed Dawoud has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Amany E. Elashkar

    Clinical Pathology Department, National Liver Institute, Menoufia University, Shebin El- Kom, Egypt

    1 shared publication
  • Amira Samy Elmaghraby

    Clinical Pathology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt

    1 shared publication
  • Asmaa Shaaban Sleem

    Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Egypt

    1 shared publication
  • Heba Abdelhalim

    Diagnostic and Interventional Radiology Department of Diagnostic Medical Imaging and Interventional Radiology, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt

    1 shared publication
  • Marwa Mohamed Ibrahim Khalil

    Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt

    1 shared publication
  • Salma Nagi

    Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Menoufia, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Assessment of IL-27 T4730C polymorphism and its serum levels in neonatal cholestasis patients

    by Amira Samy Elmaghraby, Salma Abdel Megeed Nagi, Amal M. Dawoud, Marwa M. Khalil, Sania Ali Yehia, Heba Abdelhalim, Amany E. Elashkar

    Background: The immune system and many genes have been linked to bile tract damage in neonatal cholestasis (NC), resulting in liver retention of biliary contents. The most commonly recognized cause of NC is biliary atresia (BA). Objectives: The study investigated the effect of the IL27 rs181206 polymorphism on NC risk and its potential association with blood IL-27 levels. Methodology: This study included 41 NC patients (20 BA and 21 non-BA), and 20 healthy controls. The diagnosis of NC has been confirmed by a cholestasis workup that includes radiographic evidence, laboratory-based analysis, and clinical observations. The genotype of the variation IL-27 rs181206 was assessed using a pre-made Taqman test. Serum levels of IL27 were determined using a double antibody sandwich enzyme-linked immunosorbent assay. Results: Compared to controls, individuals with NC had a greater frequency of the T allele (98.8% vs. 60%) ( P value 0.002). Those with the TT genotype had a 17.14-fold increased risk of developing NC in the dominant model [OR, 17.14 (95% CI, 1.89 to 155.14); P = 0.004]. NC infants had significantly higher serum levels of IL-27 (98.180 ± 34.96 for BA and 100.757 ± 46.42 for non-BA) than controls (76.070 ± 5.8650). However, IL-27 serum levels did not differ significantly among different genotypes. Conclusion: The T allele and TT genotype could increase the risk of NC susceptibility. Understanding IL27’s role in NC pathogenesis can help to use it as a diagnostic marker or therapeutic target.

  • Assessment of antibacterial and anti-biofilm activity of probiotic lactobacillus against biofilm-forming Proteus mirabilis clinical isolates

    by Amal Mohamed Dawoud, Samar Shawky Salman, Asmaa Shaaban Sleem

    Background: Emergence of biofilm-producing P. mirabilis, especially those resistant to conventional antibiotics, necessitates safe and natural alternatives like probiotics. We investigated the potential antimicrobial and anti-biofilm activities of L. acidophilus and L. reuteri against P. mirabilis clinical isolates.Methodology: P. mirabilis colonies were identified by traditional methods. Antimicrobial susceptibility and biofilm formation were assessed by disk diffusion and microtiter plate assay (MTP) respectively. L. acidophilus and L. reuteri were incubated in De Man, Rogosa and Sharpe broth, then centrifuged to get cell free supernatant. Antimicrobial and anti-biofilm effect of supernatant against P. mirabilis were tested using agar well diffusion and MTP methods, respectively.Results: About 61.3% of P. mirabilis isolates were biofilm producers with 92% and 30.7% for ampicillin and imipenem resistance, respectively. Multi-drug resistance represented 42.7%. Supernatants of L. acidophilus and L. reuteri had 100% antimicrobial inhibition for untreated and 56% and 68% respectively for treated one with mean inhibition zone diameters 18.65±1.05 and 18.32±1.08 respectively for untreated and 8.44±7.54 and 10.0±6.93 respectively for treated supernatant. L. acidophilus supernatant showed significant reduction of biofilm formation by ≥78% and ≥75% for L. reuteri. Treated and untreated supernatant showed significant eradication of maturely formed biofilm by 37% - 70% for L. acidophilus and 40%- 66% respectively for L. reuteri.Conclusion: L. acidophilus and L. reuteri demonstrated antibacterial and anti-biofilm activity that with further in vivo and in vitro testing can be employed as a novel antimicrobial agent against P. mirabilis.